MOLECULAR GENETIC MARKERS FOR DIAGNOSING METACHRONOUS ONCOGYNECOLOGICAL TUMORS IN BREAST CANCER PATIENTS
loading.default
item.page.date
item.page.authors
item.page.journal-title
item.page.journal-issn
item.page.volume-title
item.page.publisher
Western European Studies
item.page.abstract
Breast cancer (BC) patients face an increased risk of developing multiple primary malignant tumors, particularly metachronous oncogynecological neoplasms. Early detection and risk stratification of these secondary malignancies are critical for improving patient outcomes.